Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)

Market Cap	28.44B
Revenue (ttm)	4.67B
Net Income (ttm)	1.25B
Shares Out	921.32M
EPS (ttm)	1.36
PE Ratio	22.69
Forward PE	21.44
Dividend	0.60 (1.81%)
Ex-Dividend Date	Jun 6, 2025

Volume	18,039,329
Average Volume	8,143,434
Open	32.29
Previous Close	33.12
Day's Range	30.51 - 33.14
52-Week Range	18.41 - 47.37
Beta	0.22
RSI	29.48
Earnings Date	Oct 29, 2025

About SHE:002773

Chengdu Kanghong Pharmaceutical Group Co., Ltd research, develops, manufactures, and distributes medicine for ophthalmic, neuropsychiatric and other applications in China. It also develops a pipeline of clinical and pre-clinical programs for ophthalmology, CNS, oncology, and common disease. Chengdu Kanghong Pharmaceuticals Group Co., Ltd. was founded in 1996 and is based in Chengdu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 4,462
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002773

Financial Performance

In 2024, SHE:002773's revenue was 4.45 billion, an increase of 12.51% compared to the previous year's 3.96 billion. Earnings were 1.19 billion, an increase of 14.02%.